Myopia Prevalence in Canadian School Children - a Pilot Study
NCT ID: NCT01942057
Last Updated: 2015-07-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
173 participants
OBSERVATIONAL
2013-12-31
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
To Evaluate the Consistency and Repeatability of Portable Automatic Optometry 2-WINS for Cycloplegic Optometry in Adolescents and Children
NCT06346626
Real-World Study of Myopia Prevention and Control in Children
NCT06849895
The Effect of Final Exam Preparation on Anxiety Level, Self-Perception, Ocular Symptoms, Accommodation and Vergence in Myopia
NCT00405106
Pilot Study of Accommodative/Vergence Therapy to Modify Accommodative Function in Children With Myopia
NCT02578407
Effect of Using Myopia Prediction Algorithm
NCT04005014
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
School Grades 1+2
Children currently enrolled in grades 1 and 2
No interventions assigned to this group
School Grades 6+7
Children currently enrolled in grades 6 and 7
No interventions assigned to this group
School Grades 11+12
Children currently enrolled in grades 11 and 12
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Has had the "letter of assent for children" explained to them, the child has agreed to participate and the letter has been signed by the study investigator and the child
* Has provided the completed Questionnaire (Appendix 4A for parents to complete on behalf of their children in school grades 1 and 2, 6 and 7; Appendix 4B for children to complete that are in school grades 11 and 12)
* Is currently in school grades 1 and 2, 6 and 7 or 11 and 12
* Is willing and able to follow instructions and maintain the appointment schedule
Exclusion Criteria
* Has known sensitivity to the diagnostic pharmaceuticals to be used in the study
* Has undergone refractive error surgery or orthokeratology
* Has serious medical disorders or eye diseases/abnormalities such as amblyopia and cataract or a cognitive inability to conduct the tests
6 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Waterloo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lyndon Jones, PhD
Role: PRINCIPAL_INVESTIGATOR
Center for Contact Lens Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre for Contact Lens Research
Waterloo, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Centre for Contact Lens Research Website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19043
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.